US Edition
Published • loading... • Updated
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $170.00 at Wolfe Research
Summary by defenseworld.net
1 Articles
1 Articles
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $170.00 at Wolfe Research
Gilead Sciences (NASDAQ:GILD – Free Report) had its price objective hoisted by Wolfe Research from $155.00 to $170.00 in a research report released on Thursday morning,MarketScreener reports. Wolfe Research currently has an outperform rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on GILD. BMO Capital Markets increased their price objective on Gilead Sciences from $135.00 to $150.00 and g…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
